Clues to quality of journals
Open Access Policy of Helmholtz Association 2016
CC Licencences
Publication Metrics
Home
Deutsch
New EVA Application
Advanced Search
Browse by ...
Publication overview
Statistics (last 5 years)
OA Publications
Submit Publication
Import publication from...
Report missing publication
Contact persons
Help
Text
Endnote (RIS)
BibTeX
Publ. Version/Full Text
DOI
PMC
 |
Open Access Hybrid |
|
as soon as is submitted to ZB.
An update on adrenocortical cell lines of human origin.
Endocrine 77, 432-437 (2022)
Adrenocortical carcinoma (ACC) is a rare, heterogenous and highly malignant disease. Management of ACC is dependent on disease stage with complete surgical resection as the only potentially curative option. However, advanced, un-resectable, metastatic stages and also recurrences often require systemic treatments, which are unfortunately nowadays still unsatisfactory. The scarcity of preclinical models reflecting patient heterogeneities and furthermore drug-resistant phenotypes, has hampered the progress and development of new therapies in recent years. In this review, we provide an overview on the classical models and substantial progress which has been made over the last years in context of this aggressive disease.
Impact Factor
Scopus SNIP
Altmetric
3.925
1.282
Annotations
Special Publikation
Hide on homepage
Publication type
Article: Journal article
Document type
Review
Language
english
Publication Year
2022
HGF-reported in Year
2022
ISSN (print) / ISBN
1355-008X
e-ISSN
1559-0100
Journal
Endocrine
Quellenangaben
Volume: 77,
Issue: 3,
Pages: 432-437
Publisher
Springer
Publishing Place
Totowa, NJ
Reviewing status
Peer reviewed
Institute(s)
Institute of Pancreatic Islet Research (IPI)
POF-Topic(s)
90000 - German Center for Diabetes Research
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502600-001
Grants
University of Zurich
WOS ID
WOS:000817846600002
Scopus ID
85133088196
PubMed ID
35764904
Erfassungsdatum
2022-07-19